The management of antiplatelet therapy in patients with coronary artery disease and thrombocytopenia
American Journal of the Medical Sciences, cilt.370, sa.2, ss.109-117, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 370 Sayı: 2
- Basım Tarihi: 2025
- Doi Numarası: 10.1016/j.amjms.2025.04.007
- Dergi Adı: American Journal of the Medical Sciences
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Veterinary Science Database
- Sayfa Sayıları: ss.109-117
- Anahtar Kelimeler: Coronary artery disease, Management, Thrombocytopenia
- Trakya Üniversitesi Adresli: Evet
Özet
Ischemic heart disease is the leading cause of death in the world. Patients who have acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) with significant thrombocytopenia are at high risk for bleeding. In the literature, studies conducted on this patient group are very few. For this reason, although it is difficult for physicians to manage antiplatelet therapy in these patients, the risk of bleeding can be minimized with some current guideline recommendations. This review aims to explore in detail the management of antiplatelet therapy in patients who have moderate and severe thrombocytopenia with coronary artery disease (CAD).